/
/
/

Bliss GVS Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015
₹286 Cr₹257 Cr₹218 Cr₹244 Cr₹207 Cr₹198 Cr₹210 Cr₹218 Cr₹184 Cr₹198 Cr₹201 Cr₹212 Cr₹160 Cr₹185 Cr₹206 Cr₹172 Cr₹189 Cr₹167 Cr₹216 Cr₹196 Cr₹168 Cr₹132 Cr₹164 Cr₹130 Cr₹130 Cr₹120 Cr₹148 Cr₹210 Cr₹212 Cr₹244 Cr₹220 Cr₹228 Cr₹205 Cr₹167 Cr₹196 Cr₹227 Cr₹226 Cr₹258 Cr₹234 Cr₹169 Cr₹141 Cr₹144 Cr₹132 Cr₹176 Cr₹95 Cr
₹10 Cr₹11 Cr₹18 Cr₹20 Cr₹35 Cr₹12 Cr₹15 Cr₹7 Cr₹4 Cr₹6 Cr₹5 Cr₹13 Cr₹5 Cr₹3 Cr₹6 Cr₹2 Cr₹7 Cr₹12 Cr₹6 Cr₹5 Cr₹8 Cr₹6 Cr₹4 Cr₹7 Cr₹7 Cr₹19 Cr₹6 Cr₹13 Cr₹2 Cr₹3 Cr-₹4 Cr₹25 Cr₹14 Cr₹6 Cr₹2 Cr₹15 Cr₹4 Cr-₹7 Cr₹8 Cr₹3 Cr₹8 Cr₹4 Cr₹6 Cr₹8 Cr₹6 Cr
₹295 Cr₹268 Cr₹237 Cr₹265 Cr₹243 Cr₹210 Cr₹226 Cr₹224 Cr₹188 Cr₹204 Cr₹206 Cr₹224 Cr₹165 Cr₹188 Cr₹211 Cr₹175 Cr₹196 Cr₹179 Cr₹222 Cr₹201 Cr₹176 Cr₹138 Cr₹168 Cr₹137 Cr₹137 Cr₹138 Cr₹153 Cr₹223 Cr₹214 Cr₹247 Cr₹217 Cr₹253 Cr₹219 Cr₹173 Cr₹198 Cr₹242 Cr₹229 Cr₹252 Cr₹242 Cr₹172 Cr₹150 Cr₹148 Cr₹139 Cr₹184 Cr₹101 Cr
₹219 Cr₹221 Cr₹192 Cr₹221 Cr₹174 Cr₹185 Cr₹188 Cr₹185 Cr₹156 Cr₹177 Cr₹164 Cr₹164 Cr₹141 Cr₹183 Cr₹163 Cr₹152 Cr₹154 Cr₹151 Cr₹187 Cr₹171 Cr₹138 Cr₹119 Cr₹130 Cr₹114 Cr₹114 Cr₹107 Cr₹118 Cr₹188 Cr₹165 Cr₹215 Cr₹179 Cr₹189 Cr₹167 Cr₹134 Cr₹154 Cr₹184 Cr₹167 Cr₹183 Cr₹200 Cr₹131 Cr₹105 Cr₹97 Cr₹106 Cr₹138 Cr₹63 Cr
₹86 Cr₹56 Cr₹53 Cr₹52 Cr₹77 Cr₹33 Cr₹45 Cr₹47 Cr₹38 Cr₹34 Cr₹49 Cr₹67 Cr₹29 Cr₹9 Cr₹53 Cr₹27 Cr₹46 Cr₹32 Cr₹40 Cr₹35 Cr₹42 Cr₹23 Cr₹42 Cr₹27 Cr₹27 Cr₹35 Cr₹38 Cr₹38 Cr₹51 Cr₹35 Cr₹40 Cr₹66 Cr₹55 Cr₹43 Cr₹50 Cr₹63 Cr₹68 Cr₹69 Cr₹53 Cr₹45 Cr₹48 Cr₹52 Cr₹35 Cr₹51 Cr₹41 Cr
₹58 L₹2 Cr₹1 Cr₹3 Cr₹5 Cr₹2 Cr₹1 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹5 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹68 L₹1 Cr₹2 Cr₹94 L₹2 Cr₹2 Cr₹5 Cr₹1 Cr₹1 Cr₹89 L₹93 L₹96 L₹1 Cr₹1 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹8 Cr₹4 Cr₹4 Cr₹4 Cr₹7 Cr₹2 Cr₹5 Cr₹5 Cr
₹75 Cr₹45 Cr₹41 Cr₹41 Cr₹63 Cr₹23 Cr₹36 Cr₹36 Cr₹30 Cr-₹4 Cr₹40 Cr₹59 Cr₹22 Cr-₹75 L₹47 Cr₹20 Cr₹39 Cr₹26 Cr-₹39 Cr₹30 Cr₹37 Cr₹17 Cr₹37 Cr₹20 Cr₹20 Cr₹13 Cr₹34 Cr₹34 Cr₹47 Cr₹32 Cr₹36 Cr₹63 Cr₹51 Cr-₹1 Cr₹39 Cr₹52 Cr₹56 Cr₹60 Cr₹38 Cr₹36 Cr₹41 Cr₹43 Cr₹31 Cr₹41 Cr₹33 Cr
₹51 Cr₹37 Cr₹25 Cr₹29 Cr₹44 Cr₹17 Cr₹26 Cr₹26 Cr₹22 Cr-₹5 Cr₹29 Cr₹43 Cr₹14 Cr₹3 Cr₹30 Cr₹16 Cr₹27 Cr₹23 Cr-₹49 Cr₹22 Cr₹26 Cr₹8 Cr₹28 Cr₹17 Cr₹17 Cr₹6 Cr₹25 Cr₹31 Cr₹33 Cr₹19 Cr₹27 Cr₹42 Cr₹39 Cr-₹14 Cr₹26 Cr₹39 Cr₹37 Cr₹43 Cr₹22 Cr₹21 Cr₹28 Cr₹29 Cr₹23 Cr₹28 Cr₹20 Cr

Share Price Live Stats

Open (₹)630.00
Volume (₹)3.23 L
High (₹)671.30
Upper Circuit671.30
Low (₹)607.40
Lower Circuit607.40
Prev Close639.35
52W High (₹)671.30
Price669.00
52W Low (₹)118.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)6768.67 Cr
Div. Yield (%)0.24
PE Ratio49.70
Debt to Equity0.00
Price to Book1.93
Book Value111.66
EPS (TTM)12.81
Face Value1.00
ROE (%)12.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
BLISSGVS-BENSE
LTP
1W Low
1W High
Market cap (₹)
1900.7-19.3 (-1.01%)
1896.80
1984.80
4,56,833Cr
9155-84 (-0.91%)
9087
9467
2,45,426Cr
4843.5-206.5 (-4.09%)
4823
5066
1,87,320Cr
1129.5-61.5 (-5.16%)
1125.10
1187
1,13,217Cr
1381.6-41.9 (-2.94%)
1376
1426.10
1,12,212Cr
1845.3-93.2 (-4.81%)
1811.70
1949
1,01,155Cr
2113.9-57.6 (-2.65%)
2107.20
2192
97,626Cr
2331.4-51.5 (-2.16%)
2327.30
2419.20
96,859Cr
1158.6-19.4 (-1.65%)
1154.40
1179.90
96,406Cr
1651.5+6.2 (0.38%)
1622.60
1717
93,614Cr
669+80.9 (13.76%)
580
671.30
6,769Cr

Key Highlights of Bliss GVS Pharma Ltd’s P&L

In 2026-03-31, Bliss GVS Pharma Ltd reported total revenue of ₹1015.45Cr, compared with ₹846.22Cr in 2025-03-31, reflecting Bliss GVS Pharma Ltd turnover.

Depreciation was ₹33.48Cr and finance costs were ₹12.01Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹189.59Cr in 2026-03-31 as compared to ₹125.64Cr in 2025-03-31.

Net Profit (PAT) was ₹129.13Cr in 2026-03-31 compared with ₹84.3Cr in 2025-03-31.

Earnings per share (EPS) were ₹12.21 in 2026-03-31, compared with ₹8 in 2025-03-31.